Published: Nov. 7, 2024
Language: Английский
Published: Nov. 7, 2024
Language: Английский
Advanced Composites and Hybrid Materials, Journal Year: 2025, Volume and Issue: 8(1)
Published: Feb. 1, 2025
Language: Английский
Citations
0Composites Part B Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 112303 - 112303
Published: Feb. 1, 2025
Language: Английский
Citations
0Small Methods, Journal Year: 2025, Volume and Issue: unknown
Published: March 30, 2025
Osteoarthritis (OA) is the most prevalent degenerative joint disorder, characterized by progressive degradation, pain, and diminished mobility, all of which collectively impair patients' quality life escalate healthcare expenditures. Current treatment options are often inadequate due to limited efficacy, adverse side effects, temporary symptom relief, underscoring urgent need for more effective therapeutic strategies. Recent advancements in nanomaterials nanomedicines offer promising solutions improving drug bioavailability, reducing effects providing targeted benefits. This review critically examines pathogenesis OA, highlights limitations existing treatments, explores latest innovations intelligent design OA therapy, with an emphasis on their engineered properties, mechanisms, translational potential clinical application. By compiling recent findings, this work aims inspire further exploration innovation nanomedicine, ultimately advancing development personalized therapies.
Language: Английский
Citations
0Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 162382 - 162382
Published: April 1, 2025
Language: Английский
Citations
0Advanced Functional Materials, Journal Year: 2025, Volume and Issue: unknown
Published: April 22, 2025
Abstract Knee osteoarthritis (KOA) is a common joint disorder characterized by progressive cartilage degeneration. MiR‐455‐3p has been identified as promising therapeutic candidate to maintain homeostasis. However, clinical application of free miR‐455‐3p limited rapid degradation, poor targeting efficiency, and off‐target effects. To overcome these limitations, an injectable nanocomposite hydrogel‐based miRNA delivery system consisting affinity nanocarrier (CANC) encapsulated within PCL‐b‐PEG‐b‐PCL hydrogel developed. The CANC formulated using 50% PEGylated G5 PAMAM dendrimers load further modified with chondrocyte‐affinity peptides (CAP) minimal “self” (MSP) enhance evade macrophage uptake. In vitro studies demonstrated that it exhibited excellent stability, low cytotoxicity, superior penetration chondrocyte targeting. Moreover, in vivo experiments knockout mice destabilization the medial meniscus (DMM) induced KOA model confirmed sustained release targeted effectively rescued degeneration prevent progression. Notably, high biocompatibility without observed cytotoxicity major organs. This study highlights potential promoting regeneration presents approach for development disease‐modifying drugs.
Language: Английский
Citations
0BioDrugs, Journal Year: 2025, Volume and Issue: unknown
Published: May 30, 2025
Language: Английский
Citations
0Published: Nov. 7, 2024
Language: Английский
Citations
0